Based on these results, several conclusions were suggested: (i) factors different from Aβ, such as tau, may act as causative substances; (ii) Aβ oligomers rather than senile plaques may evoke AD pathology; (iii) treatment was delayed after the onset of AD symptoms started to appear. Here, MAPT is linked to Alzheimer disease.